Formulation Development

Formulation Development
Product Description

Recipharm offer formulation development services for all dosage forms. We develop everything from simple formulations for early studies to more complex formulations suited for commercialisation.

Recipharm AB

  • SE
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator

Recipharm AB

  • SE
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator

More Products from Recipharm AB (4)

  • Development & manufacture - drug delivery devices

    Product Development & manufacture - drug delivery devices

    Bespak by Recipharm delivers market leading design, development, and manufacturing services for drug delivery devices to the global pharmaceutical market. Our portfolio includes inhalers, nasal technologies, and auto-injectors as well as development and manufacturing services.
  • Drug Product

    Product Drug Product

    At Recipharm, we offer drug product development services for all common dosage forms. Our team can manage the complexity of your project, helping you find the best solution whether you are looking for development support to take your product to first-in-human (FIH) studies or to advance your product to market...
  • Drug Substance

    Product Drug Substance

    Recipharm has more than 25 years’ experience in drug substance development and manufacturing. We are ideally placed to deliver a wide range of drug substance services from our dedicated development facilities around the world.
  • Integrated technology platform

    Product Integrated technology platform

    An integrated service for inhalation drug products and devices spanning early-stage development to commercial manufacture. Our depth of knowledge means we can overcome the challenges associated with inhalation drug products and devices.

Recipharm AB resources (7)

  • News Recipharm streamlines operations by selling oral solid dosage manufacturing site

    Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon
  • Brochure Recipharm Analytical Solutions™

    Through Recipharm Analytical Solutions™, we support customers with stand-alone analytical requirements.Our analytical development team has experience from developing hundreds of analytical methods every year,supporting development of formulations ranging from powder in capsules and IV solutions to ER tablets and drypowder inhalers. This means our 160-strong team of chemists are prepared for any challenge.
  • Technical Data Recipharm Inhalation Solutions™

    At Recipharm, we support inhalation product developmentand manufacturing through our end-to-end service offering,Recipharm Inhalation Solutions™.
  • Whitepaper A stability indicating method for analysis of a complex drug product

    Find out how Recipharm developed a suitable analysis method for Lecigon® intestinal gel, a combination drug product containing three active pharmaceutical ingredients.
  • Podcast CPHI Podcast Series: Selecting the Right CDMO Outsourcing Partner

    Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector, gaining access to manufacturing capacity and state-of-the-art equipment and scaling up to the commercial level are just three examples. With so many outsourcing options available, selecting the CDMO that is the right fit for any particular sponsor company can be a challenging task. We speak with Frank Ternes, Chief Commercial Officer and Filip Ringborg, Director Contract Management & Operations Development, at Recipharm on best practice when it comes to selecting the right fit for your outsourcing requirements and how strategic partnerships built on trust are fundamental to success.
  • Webinar CPHI Webinar Series Pharma Trend Outlook 2022

    As we approach the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event, we’re looking ahead to what 2022 has in store for the pharma industry. In this 60 minute, free-to-attend webinar, you’ll have the opportunity to hear from market experts from different sectors of the industry on the key trends, dynamics and disruptors we can anticipate in the coming year. Sourcing dynamics, the shift to self-administration, biotech innovation and sustainability are all high on the agenda – join us as we explore where the biggest opportunities and challenges lie and build your knowledge on where the industry is heading.